Sattva Neelapu
Sattva Neelapu
absence cancer cancers diseased human number responses study treated vaccine vaccines
This is the first human cancer vaccine study to see T-cell responses in the absence of B-cells. This paves the way to use vaccines in a number of hematological cancers that are treated by eliminating diseased B-cells.
began cells fifth fourth produced recovering response seen third tumor
After the third vaccination, we began to see T-cell responses. An antibody response to the tumor produced by recovering B cells was seen after the fourth or fifth vaccination.
cancers diseased number treated vaccines
This paves the way to use vaccines in a number of hematological cancers that are treated by eliminating diseased B cells.